Eli Lilly and Co (LLY)
425.79
-1.52
(-0.36%)
USD |
NYSE |
May 26, 16:00
425.00
-0.79
(-0.19%)
After-Hours: 20:00
Eli Lilly Revenue (TTM): 27.69B for March 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2023 | 27.69B |
| December 31, 2022 | 28.54B |
| September 30, 2022 | 29.24B |
| June 30, 2022 | 29.07B |
| March 31, 2022 | 29.32B |
| December 31, 2021 | 28.32B |
| September 30, 2021 | 27.76B |
| June 30, 2021 | 26.73B |
| March 31, 2021 | 25.49B |
| December 31, 2020 | 24.54B |
| September 30, 2020 | 23.21B |
| June 30, 2020 | 22.95B |
| March 31, 2020 | 23.09B |
| December 31, 2019 | 22.32B |
| September 30, 2019 | 21.84B |
| June 30, 2019 | 21.67B |
| March 31, 2019 | 21.62B |
| December 31, 2018 | 21.49B |
| September 30, 2018 | 19.12B |
| June 30, 2018 | 19.47B |
| March 31, 2018 | 19.71B |
| December 31, 2017 | 19.97B |
| September 30, 2017 | 22.47B |
| June 30, 2017 | 22.00B |
| March 31, 2017 | 21.59B |
| Date | Value |
|---|---|
| December 31, 2016 | 21.22B |
| September 30, 2016 | 20.84B |
| June 30, 2016 | 20.61B |
| March 31, 2016 | 20.18B |
| December 31, 2015 | 19.96B |
| September 30, 2015 | 19.70B |
| June 30, 2015 | 19.62B |
| March 31, 2015 | 19.58B |
| December 31, 2014 | 19.62B |
| September 30, 2014 | 20.30B |
| June 30, 2014 | 21.20B |
| March 31, 2014 | 22.19B |
| December 31, 2013 | 23.11B |
| September 30, 2013 | 23.26B |
| June 30, 2013 | 22.93B |
| March 31, 2013 | 22.60B |
| December 31, 2012 | 22.60B |
| September 30, 2012 | 22.69B |
| June 30, 2012 | 23.40B |
| March 31, 2012 | 24.05B |
| December 31, 2011 | 24.29B |
| September 30, 2011 | 24.43B |
| June 30, 2011 | 23.93B |
| March 31, 2011 | 23.43B |
| December 31, 2010 | 23.08B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
19.12B
Minimum
Sep 2018
29.32B
Maximum
Mar 2022
24.67B
Average
23.88B
Median
Revenue (TTM) Benchmarks
| Amgen Inc | 26.19B |
| Biogen Inc | 10.10B |
| Johnson & Johnson | 96.26B |
| Merck & Co Inc | 57.87B |
| Pfizer Inc | 92.95B |